In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia's medtech impact study enters data evaluation phase

This article was originally published in Clinica

Executive Summary

Australia's study into the impact of advances in medical technology on healthcare spending closes on November 30. A call for contributions was made at the end of August, in a project set up by the Australian government productivity commission that aims to improve the level of understanding about the relationship between medtech advances, health outcomes and health expenditures among governments and other healthcare stakeholders.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060287

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel